Evoke Pharma - 11 Year Stock Price History | EVOK

Historical daily share price chart and data for Evoke Pharma since 2013 adjusted for splits and dividends. The latest closing stock price for Evoke Pharma as of November 21, 2024 is 4.50.
  • The all-time high Evoke Pharma stock closing price was 2014.56 on October 04, 2013.
  • The Evoke Pharma 52-week high stock price is 17.41, which is 286.9% above the current share price.
  • The Evoke Pharma 52-week low stock price is 3.54, which is 21.3% below the current share price.
  • The average Evoke Pharma stock price for the last 52 weeks is 7.14.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Evoke Pharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 6.3560 12.3600 12.8400 3.8700 4.5000 -64.30%
2023 23.0008 32.4012 69.0000 11.5488 12.6036 -60.81%
2022 45.3896 85.3056 123.8400 17.2476 32.1600 -59.39%
2021 228.7462 388.8000 635.0400 79.2000 79.2000 -78.68%
2020 408.0478 230.4000 820.7999 118.0656 371.5200 59.26%
2019 184.8911 367.2000 460.8000 76.3488 233.2800 -34.68%
2018 368.5193 338.4000 479.5200 273.6000 357.1200 9.73%
2017 398.2520 298.0800 558.7200 298.0800 325.4400 11.88%
2016 504.3054 469.4400 1568.1599 207.3600 290.8800 -38.79%
2015 719.6799 869.7599 1130.3999 368.6400 475.2000 -44.07%
2014 1087.1332 1110.2399 1707.8399 679.6800 849.5999 -20.81%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.006B $0.005B
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.395B 6.36
Dr Reddy's Laboratories (RDY) India $11.853B 22.68
BridgeBio Pharma (BBIO) United States $4.426B 0.00
Bausch Health Cos (BHC) Canada $2.931B 2.13
Amphastar Pharmaceuticals (AMPH) United States $2.186B 13.14
Supernus Pharmaceuticals (SUPN) United States $2.000B 27.23
Taysha Gene Therapies (TSHA) United States $0.506B 35.29
Personalis (PSNL) United States $0.245B 0.00
Assembly Biosciences (ASMB) United States $0.096B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Teligent (TLGT) United States $0.000B 0.00